Evelyne Muller

Title: Evelyne Muller: Innovator in RNA Technology

Introduction

Evelyne Muller is a prominent inventor based in Lausanne, Switzerland. She has made significant contributions to the field of molecular biology, particularly in the development of RNA technologies. Her innovative work has led to the creation of a patented invention that holds promise for various applications in genetic research and therapeutics.

Latest Patents

Evelyne Muller holds a patent for a modified short interfering RNA (siRNA) molecule. This invention refers to a double-stranded siRNA comprising a sense strand and an antisense strand that is essentially complementary to the sense strand. Each strand consists of at least 17 nucleotides, and the siRNA includes at least one overhang at the 5' and/or 3' end. The overhang residues are chemically modified and selected from a group that includes 2'-deoxy modified nucleotides, 2'-methoxy modified nucleotides, and other specific modifications. This innovative approach enhances the functionality of siRNA in various applications.

Career Highlights

Evelyne Muller is currently associated with Qiagen GmbH, a leading company in the field of molecular diagnostics and life sciences. Her work at Qiagen has allowed her to further explore and develop her innovative ideas in RNA technology. With her expertise, she has contributed to advancing the understanding and application of RNA molecules in research and therapeutic contexts.

Collaborations

Evelyne has collaborated with notable colleagues such as Stefan Pitsch and Ioanna Andreou. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Evelyne Muller is a trailblazer in RNA technology, with a patented invention that showcases her innovative spirit and dedication to scientific advancement. Her contributions continue to influence the field and pave the way for future discoveries.